Clinical data revealed that high levels of PTTG3P significantly correlate with the invasive and aggressive characteristics of HCC (positively correlated with tumor size and TNM stage) as well as poor survival in patients with HCC. Here, PTTG3P is linked to hepatocellular carcinoma.